TYSABRI sol inj 150 mg/ml ser pré 2 x 1 ml
7680680080016
CH-68008
L04AA23
01.99.0.
Reimbursement limitations:
TYSABRI4
Au moment de la pose de l'indication ou avant le traitement, le risque de LEMP …
1 / 3
google
Details
- Product number
- 6800801
- CPT
- -
- Packaging group
- 2
- Unit
- Fertigspritze(n)
- Composition
- natalizumabum 150 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.45 mg.
Articles (1)
Tysabri 150 mg/ml, Injektionslösung in einer Fertigspritze
Injektionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.45 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1700.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2022
Authorization holder
Biogen Switzerland AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68008
- Drug name
- Tysabri, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AA23
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/11/2021
- Authorization expiration date
- 03/11/2026
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TYSABRI sol inj 150 mg/ml ser pré 2 x 1 ml
- Description (DE)
- TYSABRI Inj Lös 150 mg/ml Fertspr 2 x 1 ml
- Market launch
- 04/11/2021
- Narcotic (BTM)
- No